• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斯威士兰接受 HIV 暴露前预防的使用者和其他就诊者的自付费用和就诊时间。

Out-of-pocket Expenses and Time Spent on Clinic Visits Among HIV Pre-exposure Prophylaxis Users and Other Clinic Attendees in Eswatini.

机构信息

Heidelberg Institute of Global Health, Medical Faculty and University Hospital, Heidelberg University, Heidelberg, Germany.

Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.

出版信息

AIDS Behav. 2023 Apr;27(4):1222-1233. doi: 10.1007/s10461-022-03859-3. Epub 2022 Oct 11.

DOI:10.1007/s10461-022-03859-3
PMID:36219271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9551250/
Abstract

User costs constitute a barrier to the uptake of HIV pre-exposure prophylaxis (PrEP), but their magnitude appears rarely assessed. In this prospective observational study, we assessed self-reported out-of-pocket expenses (OOPE) and time spent on clinic visits during a PrEP demonstration project in Eswatini. At six public primary care clinics, 240 PrEP users and other clinic attendees were interviewed after a clinic visit. Among the 79.2% of clinic attendees reporting any medical OOPE (e.g., expenses for consultations or drugs) and/or non-medical OOPE (e.g., expenses for transport, food, or phone use), the median total OOPE was $1.36 (IQR 0.91-1.96). Non-medical OOPE occurred mostly due to transport expenses. The median travel time for a clinic visit was 1.0 h (IQR 0.67-2.0). The median time spent in the clinic was 2.0 h (IQR 1.15-3.0). The median opportunity cost of a clinic visit was $7.54 (IQR 5.42-11) when valuing time spent on a clinic visit with Eswatini's per-capita gross domestic product. Our findings can guide measures to reduce the user costs of PrEP in Eswatini and other contexts in which oral PrEP is provided through health care facilities.

摘要

使用者成本是 HIV 暴露前预防 (PrEP) 推广的障碍,但使用者成本的规模似乎很少被评估。在这项前瞻性观察研究中,我们评估了斯威士兰 PrEP 示范项目中自我报告的自付费用(OOPE)和诊所就诊时间。在六家公立初级保健诊所,240 名 PrEP 用户和其他诊所就诊者在就诊后接受了访谈。在报告任何医疗 OOPE(例如咨询或药物费用)和/或非医疗 OOPE(例如交通、食物或电话使用费用)的诊所就诊者中,79.2%的人报告了 OOPE,其中中位数总 OOPE 为 1.36 美元(IQR 0.91-1.96)。非医疗 OOPE 主要是由于交通费用造成的。诊所就诊的中位数旅行时间为 1.0 小时(IQR 0.67-2.0)。诊所就诊的中位数时间为 2.0 小时(IQR 1.15-3.0)。当将诊所就诊时间的价值与斯威士兰人均国内生产总值进行比较时,诊所就诊的中位数机会成本为 7.54 美元(IQR 5.42-11)。我们的研究结果可以为减少斯威士兰和其他通过医疗保健机构提供口服 PrEP 的情况下 PrEP 的使用者成本的措施提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dace/10036413/36fcecab29ad/10461_2022_3859_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dace/10036413/36fcecab29ad/10461_2022_3859_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dace/10036413/36fcecab29ad/10461_2022_3859_Fig1_HTML.jpg

相似文献

1
Out-of-pocket Expenses and Time Spent on Clinic Visits Among HIV Pre-exposure Prophylaxis Users and Other Clinic Attendees in Eswatini.斯威士兰接受 HIV 暴露前预防的使用者和其他就诊者的自付费用和就诊时间。
AIDS Behav. 2023 Apr;27(4):1222-1233. doi: 10.1007/s10461-022-03859-3. Epub 2022 Oct 11.
2
User and healthcare provider early experiences with the PrEP ring: a quantitative study on the introduction of a new PrEP method in Eswatini.使用者与医疗服务提供者使用暴露前预防环的早期体验:斯威士兰引入一种新的暴露前预防方法的定量研究
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26490. doi: 10.1002/jia2.26490.
3
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.在非洲青春期少女和年轻女性中,每月使用地蒽酚阴道环或口服恩曲他滨/替诺福韦酯预防 HIV 的依从性、安全性和选择:一项随机、开放标签、交叉试验。
Lancet HIV. 2023 Dec;10(12):e779-e789. doi: 10.1016/S2352-3018(23)00227-8. Epub 2023 Oct 25.
4
Impact of changing pre-exposure prophylaxis regimens on retention among men who have sex with men in Hanoi, Vietnam (2020-2023): a cohort study.越南河内男男性行为者中暴露前预防方案变化对留存率的影响(2020 - 2023年):一项队列研究
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26478. doi: 10.1002/jia2.26478.
5
Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.与注射吸毒者接受和坚持使用 HIV 暴露前预防措施相关的因素:曼谷替诺福韦研究的一项观察性、开放性扩展研究。
Lancet HIV. 2017 Feb;4(2):e59-e66. doi: 10.1016/S2352-3018(16)30207-7. Epub 2016 Nov 18.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
High acceptability, feasibility and sustainability of a direct-to-pharmacy differentiated PrEP delivery model in public health HIV clinics in Kenya: perspectives of PrEP clients and healthcare providers.肯尼亚公共卫生艾滋病毒诊所中直接面向药房的差异化暴露前预防(PrEP)服务模式具有高度可接受性、可行性和可持续性:PrEP服务对象及医疗服务提供者的观点
J Int AIDS Soc. 2025 Jul;28 Suppl 3(Suppl 3):e26442. doi: 10.1002/jia2.26442.
8
Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.在中国、澳大利亚和泰国优化男男性行为者的 HIV 暴露前预防和检测策略:一项建模研究和成本效益分析。
Lancet Glob Health. 2024 Feb;12(2):e243-e256. doi: 10.1016/S2214-109X(23)00536-3.
9
Willingness to use long-acting injectable pre-exposure prophylaxis among key populations at a large HIV prevention clinic in Kampala, Uganda: a cross-sectional study.乌干达坎帕拉一家大型艾滋病预防诊所中重点人群使用长效注射暴露前预防药物的意愿:一项横断面研究。
AIDS Res Ther. 2025 Aug 22;22(1):81. doi: 10.1186/s12981-025-00747-3.
10
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social-emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study.肯尼亚孕期暴露于HIV暴露前预防药物与儿童早期出生、生长及社会情感发育结局的前瞻性队列研究
Lancet Glob Health. 2025 Mar;13(3):e467-e478. doi: 10.1016/S2214-109X(24)00471-6.

引用本文的文献

1
HIV knowledge and reported stigma among South Florida health fair participants.南佛罗里达健康博览会参与者的艾滋病知识及所报告的耻辱感
PLoS One. 2025 Aug 19;20(8):e0329665. doi: 10.1371/journal.pone.0329665. eCollection 2025.
2
The pathway to delivering injectable CAB for HIV prevention: strategies from global PrEP leaders leveraging an adapted version of the Intervention Scalability Assessment Tool (ISAT).提供可注射长效卡博特韦用于艾滋病预防的途径:全球暴露前预防领导者利用干预可扩展性评估工具(ISAT)的改编版本制定的策略
Implement Sci Commun. 2024 Sep 18;5(1):101. doi: 10.1186/s43058-024-00637-1.
3
Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.

本文引用的文献

1
Human resource needs and costs for HIV pre-exposure prophylaxis provision in nurse-led primary care in Eswatini and opportunities for task sharing.在斯威士兰,由护士主导的初级保健中提供艾滋病毒暴露前预防所需的人力资源和成本,以及任务分担的机会。
Hum Resour Health. 2022 Oct 23;20(1):75. doi: 10.1186/s12960-022-00770-9.
2
Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations.口服暴露前预防(PrEP)预防 HIV:对所有人群的临床效果、安全性、依从性和风险补偿的系统评价和荟萃分析。
BMJ Open. 2022 May 11;12(5):e048478. doi: 10.1136/bmjopen-2020-048478.
3
妇女和女童对长效避孕产品的偏好:在斯威士兰、肯尼亚和南非进行的定量调查和离散选择实验。
AIDS Behav. 2024 Mar;28(3):936-950. doi: 10.1007/s10461-023-04202-0. Epub 2023 Nov 16.
4
Online-Mediated HIV Pre-exposure Prophylaxis Care and Reduced Monitoring Frequency for Men Who Have Sex With Men: Protocol for a Randomized Controlled Noninferiority Trial (EZI-PrEP Study).在线介导的男男性行为者HIV暴露前预防护理及降低监测频率:一项随机对照非劣效性试验方案(EZI-PrEP研究)
JMIR Res Protoc. 2023 Nov 8;12:e51023. doi: 10.2196/51023.
5
Human resource needs and costs for HIV pre-exposure prophylaxis provision in nurse-led primary care in Eswatini and opportunities for task sharing.在斯威士兰,由护士主导的初级保健中提供艾滋病毒暴露前预防所需的人力资源和成本,以及任务分担的机会。
Hum Resour Health. 2022 Oct 23;20(1):75. doi: 10.1186/s12960-022-00770-9.
PrEP uptake and delivery setting preferences among clients visiting six healthcare facilities in Eswatini.
在斯威士兰的六家医疗机构就诊的客户对接受 PrEP 的意愿和服务提供地点的选择。
AIDS Behav. 2022 Oct;26(10):3345-3355. doi: 10.1007/s10461-022-03646-0. Epub 2022 Apr 16.
4
The Costs of Creatinine Testing in the Context of a HIV Pre-Exposure Prophylaxis Demonstration Project in Eswatini.斯威士兰艾滋病毒暴露前预防示范项目中肌氨酸酐检测的成本。
AIDS Behav. 2022 Mar;26(3):728-738. doi: 10.1007/s10461-021-03432-4. Epub 2021 Aug 18.
5
Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study.采纳和使用口腔暴露前预防指南:全球概述和预测研究。
Lancet HIV. 2021 Aug;8(8):e502-e510. doi: 10.1016/S2352-3018(21)00127-2. Epub 2021 Jul 12.
6
Health system adaptations and considerations to facilitate optimal oral pre-exposure prophylaxis scale-up in sub-Saharan Africa.促进撒哈拉以南非洲地区最佳口腔暴露前预防措施扩大规模的卫生系统适应和考虑因素。
Lancet HIV. 2021 Aug;8(8):e511-e520. doi: 10.1016/S2352-3018(21)00129-6. Epub 2021 Jul 12.
7
The Impact of Immediate Initiation of Antiretroviral Therapy on Patients' Healthcare Expenditures: A Stepped-Wedge Randomized Trial in Eswatini.即刻启动抗逆转录病毒疗法对患者医疗保健支出的影响:斯威士兰的一项阶梯式随机试验。
AIDS Behav. 2021 Oct;25(10):3194-3205. doi: 10.1007/s10461-021-03241-9. Epub 2021 Apr 8.
8
"I Just Decided to Stop:" Understanding PrEP Discontinuation Among Individuals Initiating PrEP in HIV Care Centers in Kenya.“我决定停药了”:肯尼亚艾滋病毒护理中心中开始接受 PrEP 的个体中停止 PrEP 的原因分析。
J Acquir Immune Defic Syndr. 2021 May 1;87(1):e150-e158. doi: 10.1097/QAI.0000000000002625.
9
Eliciting Preferences for HIV Prevention Technologies: A Systematic Review. eliciting preferences for hiv prevention technologies: a systematic review.
Patient. 2021 Mar;14(2):151-174. doi: 10.1007/s40271-020-00486-9. Epub 2020 Dec 15.
10
A stepped-wedge randomized trial and qualitative survey of HIV pre-exposure prophylaxis uptake in the Eswatini population.一项关于斯威士兰人群中艾滋病病毒暴露前预防措施采用情况的阶梯楔形随机试验和定性调查。
Sci Transl Med. 2020 Sep 23;12(562). doi: 10.1126/scitranslmed.aba4487.